BLymphocyte Activation and Function I Structural Basis of Antibody Diversity Lecture C409M

1 / 43
About This Presentation
Title:

BLymphocyte Activation and Function I Structural Basis of Antibody Diversity Lecture C409M

Description:

http://www.classwire.com/Login (website for Text Book) ... http://www.whfreeman.com/kuby/ (has good self test) ... Note: Pepsin cleaves IgG into one (Fab')2 fragment. ... –

Number of Views:225
Avg rating:3.0/5.0
Slides: 44
Provided by: Michael1809
Category:

less

Transcript and Presenter's Notes

Title: BLymphocyte Activation and Function I Structural Basis of Antibody Diversity Lecture C409M


1
B-Lymphocyte Activation and Function IStructural
Basis of Antibody DiversityLecture C4-09M
  • Reading in The Immune System by Parham Chapter
    2 (pages 31-47)
  • Helpful web sites
  • http//www.classwire.com/Login (website for Text
    Book)
  • http//www.medicine.dal.ca/micro/education/pimunit
    /home.htm
  • http//www.whfreeman.com/kuby/ (has good self
    test)
  • http//www-micro.msb.le.ac.uk/MBChB/ImmGloss.html
    (Glossary of terms)

2
INNATE VS. ADAPTIVE IMMUNITY
  • Innate immunity
  • involves largely phagocytic cells (granulocytes
    and macrophages) and provides a first line of
    defense.
  • Innate immunity deals with the diversity of
    pathogens that a person might encounter in their
    lifetime by having available (at all times) a few
    types of recognition molecules, each of which
    recognize a large number of pathogens.
  • Adaptive immunity
  • is stimulated by exposure to infectious agents
    and increases in magnitude and defensive
    capability with each successive exposure to a
    particular pathogen.
  • Adaptive immunity is mediated by lymphocytes
  • B-lymphocytes (also called B-cells) and
    T-lymphocytes (also called T-cells).

3
ADAPTIVE IMMUNITY
  • B-cells (along with T-cell help) synthesize
    antibodies that mediate humoral immunity and
    T-cells are major players in cellular immunity.
  • The mechanisms of adaptive immunity are ones that
    improve recognition rather than destruction.
  • Somatic gene rearrangement and somatic mutation
    in the genes for antigen receptors provide the
    lymphocyte population with a set of highly
    diverse antigen receptors, which collectively
    have the ability to recognize a vast array of
    antigens.
  • An individual lymphocyte expresses receptors of a
    single and unique antigen-binding specificity.

4
ADAPTIVE IMMUNITY
  • B cells and T cells recognize different types of
    antigens. B-cell receptors bind whole molecules
    and intact pathogens, whereas T cell receptors
    only interact with pathogen-derived peptides
    bound to proteins of the major histocompatibility
    complex.
  • IMMUNOLOGICAL MEMORY Both B cells and T cells
    of the adaptive immune system remember each
    encounter with a pathogen or foreign antigen, so
    that subsequent encounters stimulate increasingly
    more effective defense mechanisms.

5
Acquired/Adaptive Immunity
  • Acquired immunity develops during a hosts
    lifetime.
  • Six major characteristics of acquired immunity
    are
  • Specificity
  • Self-nonself discrimination
  • Inducible
  • Diversity
  • Memory
  • Self-limiting

6
(No Transcript)
7
STRUCTURAL BASIS OF ANTIBODY DIVERSITY
  • Antibodies are the antigen-specific products of B
    cells, and the production of antibody in response
    to infection is the main contribution of B cells
    to adaptive immunity.
  • The antibody molecule has two separate functions
  • one is to bind specifically to molecules from the
    pathogen that elicited the immune response
  • the other is to interact with various cells and
    molecules to destroy the pathogen once the
    antibody is bound to it.
  • These functions are structurally separated in the
    antibody molecule, one part of which specifically
    recognizes antigen and the other engages effector
    mechanisms that dispose of it.
  • The antigen-binding region varies extensively
    between antibody molecules and thus is known as
    the variable region or V region.
  • The region of the antibody molecule that engages
    the effector functions of the immune system does
    not vary in the same way and is thus called the
    constant region or C region.

8
Concept Antibodies are composed of polypeptides
with variable and constant regions.
9
Concept The antibody molecule can readily be
cleaved in to functionally distinct fragments.
Note Papain cleaves the IgG into three pieces
two Fab (Fragment antigen binding) fragments and
one Fc fragment (Fragment crystalizable).
Note Pepsin cleaves IgG into one (Fab)2
fragment. The Fc is broken into several smaller
fragments.
10
Concept All classes of antibody have the same
basic structure. Two identical heavy chains and
two identical light chains each of which
contributes to antigen binding.
The Structural Organization of the Human
Immunoglobulin Isotypes.
11
HEAVY CHAINS
  • All heavy chains are made up of discrete domains.
  • The amino terminal domain, of VH, displays the
    greatest variability.
  • The remaining domains, of CH, of the heavy chain
    form the constant region.
  • There are five classes of heavy chains
    designated ?, a, µ, d, e.
  • ? and a are further divided into subclasses ?1,
    ?2, ?3, ?4 and a1 a2 thus .
  • There are nine isotypes of antibodies as defined
    by the heavy chains.
  • All heavy chains are expressed in one of two
    molecular forms, fluid phase and membrane bound
    forms.

12
Light CHAINS
  • All antibody light chains fall into two classes
  • ? (kappa) and ? (lambda).
  • Each light chain, whether ? or ?, is folded into
    separate V and C domains.
  • There is a single gene for the kappa constant
    region, thus there is a single isotype of kappa
    chains.
  • There are six separate genes for the constant
    region of lambda chains, thus, there are six
    isotypes of lambda chain.

13
Immunoglobulin Domains
  • Both H and L chains contain several homologous
    units of about 110 amino acids termed a DOMAIN.
  • Each domain contains an intrachain disulfide bond
    which forms a loop of approximately 60 amino
    acids.
  • L chains contain one variable domain (VL), and
    one constant domain (CL)
  • H chains contain one variable domain (VH) and
    either three or four constant domains (CH1,
    CH2, CH3, and CH4) depending on the antibody
    class.

14
General Structures of the Five Classes of
Immunoglobulins in Serum
IgE
IgG
IgD
IgA (dimer)
IgM (pentamer)
Note The heavy and light chains of an
immunoglobulin molecule are
made up of similar protein domains.
15
Immunoglobulin Isotypes are Selectively
Distributed in the Body
  • The principal immunoglobulins in plasma are IgG,
    IgA and IgM (the concentration is IgGgtIgAgtIgM.
    In a healthy host IgM is found only in the
    plasma, whereas IgG and IgA are found in other
    compartments.
  • IgG and monomeric IgA are the major isotypes in
    the extracellular fluid.
  • IgG is the only isotype to cross the placenta.
  • Dimeric IgA is the predominate isotype in
    secretions across epithelia.
  • IgE is associated mainly with mast cells and
    basophiles (subject of a later lecture).
  • IgD is predominately found as a receptor on B
    cells.
  • In healthy individuals the Ig concentration in
    the CNS is low.

16
Concept An antigen-binding site is formed from
the hypervariable regions of a H-chain and
L-chain V domain.
  • The amino-terminal domain of both H and L chains
    is termed a variable (V) region due to the
    discovery of extensive seequence divergence
    between different antibody proteins in this part
    of the molecule. These are designated VH and VL
    for H and L chains, respectively.
  • V regions have been demonstrated to be
    responsible for antigen specificity of the
    immunoglobulin.
  • Sequence analysis of many VH and VL domains
    revealed that variability is concentrated in
    several hypervariable (HV) regions.
  • There are three hypervariable regions in each VH
    and VL domain.
  • The stretches of amino acid between the HVs are
    termed framework regions and these exhibit far
    less variability.
  • The interaction between the HVs of the H and L
    chains form the antigen binding site of the
    antibody molecule.
  • Since these HVs fold into a structure that is
    complementary to the antigen epitope, the HVs are
    also called complementarity-determining regions
    (CDRs).

17
Antigen Combining Site
A
L-chain HVs
  • Schematic of and IgG molecule showing the
    approximate location of the hypervariable regions
    (CDRs).
  • Schematic showing how the CDRs in each heavy- and
    light-chain pair for an antigen binding site.

H-chain HVs
  • 1. Hypervariable Regions (HV) areas of extreme
    variability in the V domain of both H and L
    chains.
  • Hypervariable regions are also called
    complementarity determining regions (CDRs).
  • Framework Regions stretches of amino acids
    between the hypervariable regions that show
    relatively less variability.

B
18
Antigen Receptor Diversity
  • The human genome is estimated to contain 34
    thousand genes (give or take a few thousand)
  • The estimated number of antibody specificities is
    estimated to be 30 million or more the number of
    T cell receptor specificities is about the same.
  • Is there a problem with these numbers?????
  • How can fewer than 105 genes encode for nearly
    108 antigen receptor specificities plus all of
    the other proteins needed by the body????????
  • The answer
  • Each receptor chain is encoded by different gene
    segments

19
CONCEPT The DNA sequence encoding a complete V
region is generated by the somatic recombination
of separate gene segments.
  • Three separate multigene families (kappa, lambda,
    and heavy chain loci) located on different
    chromosomes encode immunoglobulin light chains
    and heavy chains.
  • In germline DNA, each multigene family contains
    numerous gene segments
  • Ig genes undergo a process of somatic DNA
    recombination or rearrangement during B cell
    development to form the variable regions of light
    chains and heavy chains.
  • Functional light-chain and heavy-chain genes are
    generated by random rearrangement of the variable
    region gene segments (two for light chains and
    three for heavy chains) in developing B lineage
    cells.

20
CONCEPT Light chain variable regions are
assembled from to gene segments V and J (for
joining).
21
REARRANGEMENT OF THE LIGHT CHAIN LOCUS
22
CONCEPT Heavy chain variable regions are
assembled from three gene segments V
(variable), D (for diversity) and J (for joining).
23
REARRANGEMENT OF THE HEAVY CHAIN LOCUS
24
CONCEPT The reaction that recombines V,D, and J
gene segments involves both lymphocyte-specific
and ubiquitous DNA-modifying enzymes that are
collectively call the recombinase complex.
  • Rearrangement of Ig genes occurs principally by a
    mechanism of excision (looping out) of the DNA
    between the various gene segments followed by
    ligation of these segments.
  • Ig gene rearrangement is a special kind of
    recombination involving non-homologous gene
    segments that is mediated by a system of enzymes.
  • The enzymes involved include
  • lymphocyte-specific enzymes, which are products
    of the recombinase activating genes (Rag1 and
    Rag2)
  • and, other nuclear DNA-modifying enzymes (DNA
    repair) that are not tissue specific.

25
RECOMBINASES
  • Recombinases (RAG-1 and RAG-2) recognize specific
    DNA sequences called recombination signal
    sequences (RSS) that flank each V, D, and J gene
    segment.
  • Recombinases are cell type-specific. They are
    active in lymphocytes but not in non-lymphoid
    cells.
  • Recombinases function in the early developmental
    stages of B and T lymphocytes and are absolutely
    required for recombination to occur.
  • Recombinase activating genes 1 and 2 (Rag-1 and
    Rag-2) are present in all cells but are only
    expressed in B and T cells.

26
CONCEPT Gene segments encoding the variable
region are joined by recombination at
recombination signal sequences (RSS).
27
CONCEPT The diversity of the immunoglobulin
repertoire is generated by four main processes.
  • Multiple inherited germline gene segments used in
    different combinations.
  • Junctional diversity antibody molecules show
    the greatest variability at the junctions of the
    variable gene segments which form the third
    hypervariable region, or CDR3. Junctional
    diversity arises by two mechanisms
  • Introduction of P-nucleotides by a feature of the
    recombination reaction that generates short
    palidromic sequences at the cut ends of the DNA
    strands.
  • N-nucleotides formed from the untemplated
    addition of nucleotides by the enzyme terminal
    deoxynucleotidyl transferase (TdT).
  • Combination of any H-chain with any L-chain.
  • Somatic Hypermutation (occurs after encounter
    with antigen).

28
CONCEPT Junctional diversity is generated
during recombination of variable gene segments.
29
CONCEPT The development of B cells proceeds
through stages defined by the rearrangement and
expression of the immunoglobulin genes.
30
The Other Side of the Coin
  • Antigens/Immunogens
  • Antigen antibody generators
  • Immunogen any substance that can elicit an
    immune response in either B cells or T cells

31
ANTIGENS/Immunogens
  • Substances capable of inducing an immune response
    are called antigens or immunogens.
  • To protect against infectious disease, the immune
    system must be able to recognize bacteria,
    bacterial products (e.g., toxins), fungi,
    parasites, and viruses as immunogens.
  • The immune system actually recognizes particular
    macromolecules of an infectious agent, generally
    either proteins or polysaccharides.
  • Proteins are the most potent immunogens with
    polysaccharides ranking second.
  • In contrast, lipids and nucleic acids of an
    infectious agent generally do not serve as
    immunogens unless they are complexed to proteins
    or polysaccharides.

32
Contribution of the Immunogen to Immunogenicity
  • FOREIGNNESS
  • In order to elicit an immune response, a molecule
    must be recognized as nonself by the biological
    system (i.e., the host).
  • MOLECULAR SIZE
  • There is a correlation between the size of a
    macromolecule and its immunogenicity. Generally,
    a molecule must have a molecular mass gt10,000
    daltons.
  • CHEMICAL COMPOSITION AND COMPLEXITY
  • Size and foreignness are not, by themselves,
    sufficient to make a molecule immunogenic other
    properties are needed. The macromolecules must
    have internal complexity. Simple polymers are
    not immunogenic.
  • SUSCEPTIBILITY TO ANTIGEN PROCESSING AND
    PRESENTATION
  • The development of most humoral and all
    cell-mediated immune responses requires
    interaction of T cells with antigen that has been
    processed and presented together with MHC
    molecules. Thus, if a macromolecule can not be
    degraded by the biological system it is not
    immunogenic.

33
SUMMARY OF THE
34
Contribution of the Biological System to
Immunogenicity
  • Even if a macromolecule has the properties that
    contribute to immunogenicity, its ability to
    produce an immune response will depend on
    certain properties of the biological system that
    the antigen encounters.
  • GENOTYPE OF THE RECIPIENT HOST
  • The genetic composition of the immunized host
    influences the type and degree of the manifested
    response.
  • HEALTH AND WELL BEING OF THE HOST
  • sickness, stress, malnutrition, and age (too old
    or too young) of the host can affect the type and
    degree of an immune response.
  • IMMUNOGEN DOSE AND ROUTE OF ADMINISTRATION
  • Too high or too low of a dose can result in a
    poor immune response (tolerance to the antigen).
    The administration route strongly influences
    which immune organs and cell populations will be
    involved in the response.

35
EPITOPES
  • The molecular sites that stimulate immune
    responses are termed epitopes or antigenic
    determinants
  • B-cell Epitopes may be sequential or
    conformational
  • B cell epitopes can be found in proteins,
    carbohydrates, lipids, chemicals, drugs, etc.
  • Haptens --Non-immunogenic substances (small
    drugs, lipids,peptides, etc) can be coupled to
    carrier proteins and then can serve as B cell
    epitopes.
  • B cells recognize antigen that is free in the
    fluid phase.
  • T-cell Epitopes are made up of sequential
    residues in a protein immunogen.
  • T cells only recognize antigen after it has been
    processed by APCs and presented in the context of
    MHC

36
CONCEPT Epitopes of a protein can be linear or
discontinuous (conformational)
A linear epitope of a protein antigen is formed
from contiguous amino acids. A discontinuous
epitope is formed from amino acids from different
parts of the polypeptide that are brought
together when the chain folds, i.e., are
dependent on the conformation of the protein.
37
Concept Epitopes can bind in pockets or grooves
or on extended surfaces in the binding site of
antibodies.
38
Forces Binding Antigen to Antibody
  • The combination of antigen with antibody is a
    non-covalent interaction.
  • Ag Ab Ag-Ab (immune complex)
  • The strength of the association is a summation of
    several weak intermolecular forces
  • Van der Waals Forces
  • Hydrogen Bonds
  • Hydrophobic interactions
  • Electrostatic (Ionic) interactions

39
(No Transcript)
40
(No Transcript)
41
Cross-Reactivity of Antibodies
  • ENIGMA If antibodies are so highly specific why
    is it often observed that they will cross-react
    with unrelated antigens?
  • Same molecular structure (structurally similar
    epitope)
  • Structural mimicry
  • Examples
  • ABO blood group antigens
  • Rheumatic heart disease
  • Post-streptoccocal glomerulonephritis

42
Summary of Antibodies
  • are glycoproteins
  • are built of subunits containing
  • two identical light chains (L chains), each
    containing about 200 amino acids
  • two identical heavy chains (H chains), which are
    at least twice as long as L chains
  • The first 100 or so amino acids at the N-terminus
    of both H and L chains vary greatly from antibody
    to antibody the are termed the variable (V)
    regions
  • unless members of the same clone (often not even
    then!), no two B cells are likely to secrete
    antibodies with the same V region
  • the amino acid sequence variability in the V
    regions is especially pronounced in 3
    hypervariable regions also called CDRs
  • the tertiary structure of the antibodies brings
    the 3 CDRs of both the H and L chains together
    to form the antigen binding site which binds the
    antigen epitope
  • Only a few different amino acids sequences are
    found in the C-terminus of the H and L chains and
    these are called constant (C) regions
  • two different kinds of C regions for L chains --
    kappa (?) and lambda (?)
  • five different kinds of C regions for H chains
  • mu (µ) chains, IgM
  • gamma (?) chains, IgG
  • alpha (a) chains, IgA
  • epsilon (e) chains, IgE
  • delta (d) chains, IgD
  • each of these 5 kinds of H chains can pair with
    either lambda or kappa L chains

43
Summary of Antigen Receptor Diversity
  • Each receptor chain is encoded by several
    different gene segments
  • the gene segments are V, D, and J for heavy
    chains and V and J for light chains
  • Each gene segment has an adjacent recombination
    signal sequenc (RSS)
  • RSSs are recognized by two recombinase proteins
    encoded by Rag-1 and Rag-2 genes
  • During the differentiation of the B cell the DNA
    is cut by the recombinase enzymes and recombined
    to make an intact gene coding for a receptor
    chain.
  • DJ joining occurs first in a developing B cells
    followed by VDJ
  • VJ recombination of light chain genes occurs
    after the successful completion of VDJ
    recombination of the heavy chain genes.
  • Random assortment of gene segments contributes to
    diversity
  • Junctional diversity, P-nucleotides and
    N-nucleotides contribute to additional receptor
    diversity.
  • Somatic hypermutation after the B cell encounters
    antigen adds additional diversity
  • Ergo little bit of DNA a whole bunch of
    antibodies
Write a Comment
User Comments (0)
About PowerShow.com